Page last updated: 2024-09-05

sorafenib and nadp

sorafenib has been researched along with nadp in 5 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(nadp)
Trials
(nadp)
Recent Studies (post-2010) (nadp)
6,5207305,25121,608253,484

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Garcia-Manero, G; Hu, Y; Huang, P; Jiang, W; Lu, W; Tian, J; Wen, S; You, X; Yu, T; Zhang, H1
Ai, Y; Cao, Y; Ma, Y; Sun, Q; Wang, J; Wang, X; Yan, B; Zhang, Z1
Cai, N; Cheng, K; Liang, H; Wen, J; Xiong, Y; Zhang, W; Zhang, Y; Zhu, J1
Luo, J; Mu, X; Wang, Z; Yang, Q; Zhao, Y1
Li, Y; Liu, M; Wang, Z; Zhao, Y; Zheng, Y1

Reviews

1 review(s) available for sorafenib and nadp

ArticleYear
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors.
    Oxidative medicine and cellular longevity, 2020, Volume: 2020

    Topics: Acetaminophen; Antineoplastic Agents; Antioxidants; Apoptosis; Artemisinins; Auranofin; Cell Death; Cisplatin; Epigenesis, Genetic; Fatty Acids; Ferroptosis; Haloperidol; Humans; Indoles; Iron; Lapatinib; Mevalonic Acid; NADP; Neoplasms; Oxidation-Reduction; Oxidative Stress; Oxygen; Quinolines; Reactive Oxygen Species; Sorafenib; Spiro Compounds; Sulfasalazine; Trigonella

2020

Other Studies

4 other study(ies) available for sorafenib and nadp

ArticleYear
Metabolic reprogramming and redox adaptation in sorafenib-resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis.
    Cancer communications (London, England), 2019, 04-04, Volume: 39, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carbon Isotopes; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; Glucose; Glutathione; Humans; Leukemia; Mass Spectrometry; Metabolomics; Mice; NADP; Oxidation-Reduction; Pentose Phosphate Pathway; Protein Kinase Inhibitors; Sorafenib

2019
Membrane Damage during Ferroptosis Is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1.
    Molecular cell, 2021, 01-21, Volume: 81, Issue:2

    Topics: Animals; Cell Line, Tumor; Cell Membrane; Concanavalin A; Cytochrome P-450 Enzyme System; Cytochrome-B(5) Reductase; Electron Transport; Fatty Acids, Unsaturated; Ferroptosis; HEK293 Cells; HeLa Cells; Humans; Hydrogen Peroxide; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; NADP; Oxygen; Phenylurea Compounds; Piperazines; Pyridines; Sorafenib

2021
Hypoxia-responsive nanocarriers for chemotherapy sensitization via dual-mode inhibition of hypoxia-inducible factor-1 alpha.
    Journal of colloid and interface science, 2022, Dec-15, Volume: 628, Issue:Pt B

    Topics: Antineoplastic Agents; Aspartic Acid; Caspase 3; Cell Hypoxia; Cell Line, Tumor; Cytochromes c; Dicumarol; Female; Glutathione; Humans; Hypoxia; Micelles; NAD; NADP; Nitroimidazoles; Oxygen; Phosphates; Polyethylene Glycols; Polymers; Quinones; Sorafenib; Thioredoxins

2022
Coenzyme-depleting nanocarriers for enhanced redox cancer therapy under hypoxia.
    Journal of colloid and interface science, 2023, Volume: 641

    Topics: Animals; Antioxidants; Cell Line, Tumor; Coenzymes; Glutathione; Humans; Hypoxia; Mice; NADP; Neoplasms; Nitroimidazoles; Oxidation-Reduction; Sorafenib

2023